US03759B1026 - Common Stock
APEXIGEN INC
NASDAQ:APGN (8/22/2023, 7:00:00 PM)
After market: 0.3807 0 (-1.14%)0.3851
+0.03 (+8.48%)
Apexigen, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in San Carlos, California and currently employs 20 full-time employees. The company went IPO on 2021-02-02. The firm is focused on discovering and developing antibody therapeutics for oncology, with an emphasis on new immuno-oncology agents designed to harness the patient’s immune system to combat and eradicate cancer. The company has developed a clinical-stage candidate, namely sotigalimab (sotiga or APX005M), which is a humanized agonist antibody. The company also has various preclinical and research-stage antibodies it discovered using its APXiMAB platform. The company is focused on completing ongoing clinical and manufacturing activities for the sotiga program. The Company’s licensees are advancing five product candidates in clinical development that were enabled by discoveries from its APXiMAB platform. APX005M is under Phase II clinical development for the treatment of solid tumors, such as soft tissue sarcomas, esophageal and gastroesophageal junction cancers and melanoma, in combination with chemotherapy, radiation therapy and immunotherapy.
APEXIGEN INC
900 Industrial Road, Suite C
San Carlos CALIFORNIA
P: 16509316236.0
Employees: 20
Website: https://www.apexigen.com/
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
- Marked increases in overall survival observed across soft tissue sarcoma patients - - Demonstrated improvement of median progression free survival in...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Here you can normally see the latest stock twits on APGN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: